betoptic s- betaxolol hydrochloride suspension/ drops
novartis pharmaceuticals corporation - betaxolol hydrochloride (unii: 6x97d2xt0o) (betaxolol - unii:o0zr1r6rz2) - betoptic s® (betaxolol hydrochloride ophthalmic suspension) 0.25% is indicated for the treatment of elevated intraocular pressure (iop) in patients with chronic open-angle glaucoma or ocular hypertension. betoptic s is contraindicated in patients with: - sinus bradycardia - greater than a first degree atrioventricular (av) block - cardiogenic shock - patients with overt cardiac failure - hypersensitivity to any component of this product risk summary there are no adequate and well-controlled studies of betoptic s administration in pregnant women to inform a drug-associated risk. there are limited data with the use of betaxolol eye drops in pregnant women. epidemiological studies have not revealed malformative effects but show a risk for intrauterine growth retardation when beta-blockers are administered by the oral route. in animal reproductive studies, no drug-induced maternal toxicity or teratogenicity was observed at clinically relevant doses (see data) . because animal reproductive studies are not always
betoptic eye drops solution 0.5%w/v %w/v
pco manufacturing - betaxolol hydrochloride - eye drops solution - 0.5%w/v %w/v
betoptic eye drops solution 0.5 %w/v
g & a licensing limited - betaxolol hydrochloride - eye drops solution - 0.5 %w/v
betoptic eye drops solution 0.5 base %w/v
ltt pharma limited - betaxolol hydrochloride - eye drops solution - 0.5 base %w/v
betoptic 0.25% eyedrops
alcon laboratories (uk) ltd - betaxolol hydrochloride - eye drops suspension - 0.25 %w/v
betoptic 0.5 %w/v eye drops solution
g & a licensing limited - betaxolol hydrochloride - eye drops solution - 0.5 %w/v
betoptic 0.25% eyedrops 0.25 %w/v eye drops suspension
alcon laboratories (uk) ltd - betaxolol hydrochloride - eye drops suspension - 0.25 %w/v
betoptic suspension single dose 0.25 %w/v eye drops suspension
alcon laboratories (uk) ltd - betaxolol hydrochloride - eye drops suspension - 0.25 %w/v - beta blocking agents
betoptic 0.5 %w/v eye drops solution
novartis pharmaceuticals uk ltd - betaxolol hydrochloride - eye drops solution - 0.5 %w/v - beta blocking agents
betoptic suspension single dose 0.25 %w/v eye drops suspension
novartis pharmaceuticals uk ltd - betaxolol hydrochloride - eye drops suspension - 0.25 %w/v - beta blocking agents